Eli Lilly is the best of both worlds — a recession-resistant stock with major growth potential

January 11, 2023 admin-dominor Biotechnology, Breaking News: Markets, business news, Earnings, Eli Lilly and Co, Health care industry, Investment strategy, Jim Cramer, MARKETS, Pharmaceuticals

The year ahead is pivotal for Eli Lilly (LLY) as the pharmaceutical giant advances its stellar drug pipeline.

Source link

← From the Shanghai upgrade to U.S. regulation: Watch these 5 events to see where crypto markets are heading in 2023
Inflation is expected to have declined in December, but it may not be enough to stop the Fed →